Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Paul Ausick | Sep 25, 2012 at 12:06 PM EDT

No News is Good News — Peregrine Pharma

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data…

Jon C. Ogg | Sep 13, 2012 at 9:06 AM EDT

Vical Scores Big License Pact with Bristol-Myers Squibb

Vical Inc. (NASDAQ: VICL) is seeing its shares surging higher on news that it has signed a worldwide, nonexclusive licensing…

Jon C. Ogg | Sep 11, 2012 at 8:23 AM EDT

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Paul Ausick | Aug 24, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

The three major U.S. stock indexes opened lower this morning but picked up some buying steam in the first hour…

Jon C. Ogg | Aug 24, 2012 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St.…

Jon C. Ogg | Aug 2, 2012 at 11:47 AM EDT

Gilead Options & New High In Stock Bring Hope For Further Upside

Gilead Sciences Inc. (NASDAQ: GILD) is seeing shares surge today on news that Bristol-Myers Squibb Co. (NYSE: BMY) has run…

Trey Thoelcke | Jul 25, 2012 at 8:11 AM EDT

Drug Giants Show Mixed Earnings (BMY, LLY)

Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.’s earnings expectations. But…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Jon C. Ogg | Jul 2, 2012 at 2:42 PM EDT

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value…

Jon C. Ogg | Jul 2, 2012 at 8:14 AM EDT

The Next Mergers & Buyouts For 2012

As of late last week we had many potentially imminent buyouts that could have hit the market. When we were…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

1 … 29 30 31 32 33 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

No News is Good News — Peregrine Pharma

Vical Scores Big License Pact with Bristol-Myers Squibb

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Gilead Options & New High In Stock Bring Hope For Further Upside

Drug Giants Show Mixed Earnings (BMY, LLY)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The Next Mergers & Buyouts For 2012

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

No News is Good News — Peregrine Pharma

Vical Scores Big License Pact with Bristol-Myers Squibb

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Gilead Options & New High In Stock Bring Hope For Further Upside

Drug Giants Show Mixed Earnings (BMY, LLY)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The Next Mergers & Buyouts For 2012

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It